Ya-Ru Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ya-Ru Yu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Chien-Kuo Lee
Graduate Institute of Immunology, National Taiwan University College of Medicine, Taipei 100, Taiwan
1 shared publication - Hsin-Hsiang Chen
Institute for Experimental Neuroimmunology, Technical University of Munich School of Medicine, Munich, Germany
1 shared publication - Shun-Hua Chen
Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
1 shared publication - Yu-Ling Hsiao
Graduate Institute of Immunology, College of Medicine, National Taiwan University , Taipei
1 shared publication
Latest Publications
- 10 July 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 211 (4) , 576-590
Plasmacytoid Dendritic Cells Enhance T-Independent B Cell Response through a p38 MAPK–STAT1 Axis
TLR signaling in B cells triggers their activation and differentiation independent of help from T cells. Plasmacytoid dendritic cells (pDCs) cooperate with B cells to boost TLR-stimulated T-independent humoral immunity; however, the molecular mechanisms remain elusive. In this study, we demonstrate that in the mouse system, the adjuvant effects of pDCs also occurred following challenge with pathogens and that follicular (FO) B cells were more sensitive to pDC-induced enhancement than were marginal zone (MZ) B cells. Moreover, pDCs migrated to the FO zones and interacted with FO B cells upon stimulation in vivo. CXCL10, a ligand for CXCR3 expressed on pDCs, was superinduced in the coculture system and facilitated the cooperative activation of B cells. Moreover, pDCs also promoted TLR-stimulated autoantibody production in FO B and MZ B cells. Ingenuity Pathway Analysis and gene set enrichment analysis revealed that type I IFN (IFN-I)–mediated JAK–STAT and Ras–MAPK pathways were highly enriched in R848-stimulated B cells cocultured with pDCs compared with B cells alone. Whereas IFN-I receptor 1 deficiency reduced pDC-enhanced B cell responses, STAT1 deficiency displayed a more pronounced defect. One of the STAT1-dependent but IFN-I–independent mechanisms was TLR-induced STAT1-S727 phosphorylation by p38 MAPK. Serine 727 to alanine mutation attenuated the synergism between pDCs and B cells. In conclusion, we uncover a molecular mechanism for pDC-enhanced B cell response and define a crucial role of the IFN-I/TLR–mediated signaling pathway through a p38 MAPK–STAT1 axis in controlling T-independent humoral immunity and providing a novel therapeutic target for treating autoimmune diseases.
- 10 July 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 211 (4) , 576-590
Plasmacytoid Dendritic Cells Enhance T-Independent B Cell Response through a p38 MAPK–STAT1 Axis
TLR signaling in B cells triggers their activation and differentiation independent of help from T cells. Plasmacytoid dendritic cells (pDCs) cooperate with B cells to boost TLR-stimulated T-independent humoral immunity; however, the molecular mechanisms remain elusive. In this study, we demonstrate that in the mouse system, the adjuvant effects of pDCs also occurred following challenge with pathogens and that follicular (FO) B cells were more sensitive to pDC-induced enhancement than were marginal zone (MZ) B cells. Moreover, pDCs migrated to the FO zones and interacted with FO B cells upon stimulation in vivo. CXCL10, a ligand for CXCR3 expressed on pDCs, was superinduced in the coculture system and facilitated the cooperative activation of B cells. Moreover, pDCs also promoted TLR-stimulated autoantibody production in FO B and MZ B cells. Ingenuity Pathway Analysis and gene set enrichment analysis revealed that type I IFN (IFN-I)–mediated JAK–STAT and Ras–MAPK pathways were highly enriched in R848-stimulated B cells cocultured with pDCs compared with B cells alone. Whereas IFN-I receptor 1 deficiency reduced pDC-enhanced B cell responses, STAT1 deficiency displayed a more pronounced defect. One of the STAT1-dependent but IFN-I–independent mechanisms was TLR-induced STAT1-S727 phosphorylation by p38 MAPK. Serine 727 to alanine mutation attenuated the synergism between pDCs and B cells. In conclusion, we uncover a molecular mechanism for pDC-enhanced B cell response and define a crucial role of the IFN-I/TLR–mediated signaling pathway through a p38 MAPK–STAT1 axis in controlling T-independent humoral immunity and providing a novel therapeutic target for treating autoimmune diseases.